Designing And Evaluating Prescription Drug Models: Lessons From The Part D Senior Savings Model – RamaOnHealthcare

The Cell and Gene Therapy Access Model

This Viewpoint discusses lessons learned from the first negotiation cycle of the Centers for Medicare & Medicaid Services’ Cell and Gene Therapy Access Model.

Designing And Evaluating Prescription Drug Models: Lessons From The Part D Senior Savings Model – RamaOnHealthcare

From 2021 to 2023, the Center for Medicare and Medicaid Innovation, also known as the CMS Innovation Center, tested the Part D Senior Savings (PDSS)

CMS Unveils Initiative to Cut Medicaid Drug Costs and Expand Access to Affordable Medications

Launching next year, the new CMS Innovation Center initiative—known as the GENEROUS Model—aims to align Medicaid drug prices with global standards, reduce prescription spending, and strengthen the program’s long-term sustainability through fairer state purchasing and transparent pricing rules.